Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 
     
     
 


 

 
     
    Advanced search
 

 
 
     
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Discussion
    References
    Article Figures

 Article Access Statistics
    Viewed2106    
    Printed104    
    Emailed1    
    PDF Downloaded133    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 


 
Table of Contents   
BRIEF COMMUNICATION  
Year : 2012  |  Volume : 5  |  Issue : 1  |  Page : 51-52
Protein losing enteropathy secondary to a pulmonary artery stent


Heart Center, University Hospital of Cologne, Germany

Click here for correspondence address and email

Date of Web Publication12-Mar-2012
 

   Abstract 

A 2-year-old patient with hypoplastic left heart syndrome presented 6 months following Fontan completion with protein-losing enteropathy (PLE). He had undergone stent implantation in the left pulmonary artery after the Norwood procedure, followed by redilation of the stent prior to Fontan completion. Combined bronchoscopic and catheterization studies during spontaneous breathing confirmed left bronchial stenosis behind the stent, and diastolic systemic ventricular pressure during expiration of 25 mm Hg. We postulate that the stent acts as a valve, against which the patient generates high expiratory pressures, which are reflected in the ventricular diastolic pressure. This may be the cause of PLE.

Keywords: Bronchial compression, stents, protein losing enteropathy

How to cite this article:
Sreeram N, Trieschmann U, Bennink G. Protein losing enteropathy secondary to a pulmonary artery stent. Ann Pediatr Card 2012;5:51-2

How to cite this URL:
Sreeram N, Trieschmann U, Bennink G. Protein losing enteropathy secondary to a pulmonary artery stent. Ann Pediatr Card [serial online] 2012 [cited 2019 Apr 19];5:51-2. Available from: http://www.annalspc.com/text.asp?2012/5/1/51/93712



   Introduction Top


Protein-losing enteropathy is a feared late complication of all forms of the Fontan operation. The etiology of this disease is unclear, but it may be associated with increased systemic venous pressure, systemic ventricular dysfunction or AV valve regurgitation, or mechanical obstructions affecting the Fontan circuit. We report a new putative cause of PLE in a young patient.

A term neonate with hypoplastic left heart syndrome underwent a Norwood type of palliation in the neonatal period, followed by a bidirectional superior cavopulmonary shunt at 4 months of age. The postoperative course was complicated by recurrent pleural effusions. Cardiac catheterization demonstrated a small left pulmonary artery which was treated by stent implantation [Figure 1]a. At 2 years of age, the stent was redilated to 10mm diameter, to match the diameter of the right pulmonary artery [Figure 1]b, followed by Fontan completion using an extracardiac conduit. In the postoperative period, the patient was diagnosed to have a stenosis of the left bronchus, but could be weaned successfully from the ventilator. Six months later, he presented with protein losing enteropathy (PLE). A combined cardiac catheterization and bronchoscopic study were performed, with the patient breathing spontaneously. There were no stenoses in the Fontan pathways. The left bronchus was severely obstructed (>70%), directly behind the stent in the left pulmonary artery [Figure 1]c and d. Simultaneous systemic ventricular and pulmonary arterial pressure traces demonstrated a rise in the ventricular diastolic pressure during expiration to 25mm Hg. During inspiration, the end diastolic pressure normalised, with a reduction in the mean pulmonary artery pressure to normal values for the Fontan physiology [Figure 1]e. Bronchial compression by aorta was also ruled out [Figure 2]. We postulate that the stent acts as a valve, with the child generating high intrathoracic expiratory pressure against the stent, which in turn is reflected in the behaviour of the ventricular diastolic pressure. The intermittent elevation in systemic venous pressure is probably causative for PLE.
Figure 1: (a) Pulmonary artery angiography after the superior cavopulmonary shunt, showing a small left pulmonary artery. (b) Left pulmonary angiography following redilation of stent to 10 mm diameter, prior to Fontan completion. (c) Bronchoscopy after Fontan completion. The thin metal probe does not pass beyond the stent in the left pulmonary artery. There was a >70% stenosis of the left main bronchus at this site. (d) Lateral radiographic projection (the stent in the left pulmonary artery is seen end on). The stent compresses the bronchus directly behind it. There is an angiographic catheter introduced retrogradely to the neo-ascending aorta. (e) Simultaneous systemic ventricular and pulmonary arterial pressure traces during spontaneous breathing. During inspiration (beats 1, 4, 7) the ventricular diastolic pressure drops to normal physiological values, with a mean pulmonary artery pressure of 12 mm Hg. During expiration (beats 2, 3 and 5, 6 and 8), the ventricular diastolic pressure increases to 25 mm Hg, with a concomitant increase in the mean pulmonary artery pressure (scale given on the right hand side of the diagram, in mm Hg)

Click here to view
Figure 2: Aortic angiography showing no bronchial compression by the aorta

Click here to view


Follow-up

The patient is currently under a trial of conservative management (oral corticosteroid therapy and albumin replacement therapy), and is at home. Reoperation (removal of the stent) and patch-plasty of the LPA is under consideration.


   Discussion Top


In current cohorts, the Fontan operation is associated with improved outcomes and increasing short and long-term survival. [1],[2] It may be expected that a significant proportion of patients will reach their teens and young adult life. Factors accounting for late attrition include systemic ventricular dysfunction, AV valve regurgitation, changes in the pulmonary vascular bed, late arrhythmias and PLE. Previous studies have demonstrated that PLE is associated with a significantly worse outcome, [3],[4] and every effort should be made to manage these patients aggressively, using a combination of optimal pharmacological therapy and surgical or catheter based interventions to relieve mechanical problems affecting the Fontan circuit. [2],[5],[6],[7] In the patient presented here, we postulate a new mechanical problem as being causative for PLE, with intermittent sharp increases in intrathoracic pressure accounting for elevation of the systemic venous pressure, and concomitant intestinal protein loss.

 
   References Top

1.Hirsch JC, Goldberg C, Bove EL, Salehian S, Lee T, Ohye RG, Devaney EJ. Fontan operation in the current era: a 15-year single institution experience. Ann Surg 2008;248:402-10.  Back to cited text no. 1
[PUBMED]    
2.Huddleston CB. The failing Fontan: options for surgical therapy. Pediatr Cardiol 2007;28:472-6.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  
3.Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: An international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998;115:1063-73.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.Meadows J, Jenkins K. Protein-losing enteropathy: Integrating a new disease paradigm into recommendations for prevention and treatment. Cardiol Young 2011;21:363-77.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.Ghanayem NS, Berger S, Tweddell JS. Medical management of the failing Fontan. Pediatr Cardiol 2007;28:465-71.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Menon SC, Dearani JA, Cetta F. Long-term outcome after atrioventricular valve surgery following modified Fontan operation. Cardiol Young 2011;21:83-8.  Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Menon S, Hagler D, Cetta F, Gloviczki P, Driscoll D. Role of caval venous manipulation in treatment of protein-losing enteropathy. Cardiol Young 2008;18:275-81.  Back to cited text no. 7
[PUBMED]  [FULLTEXT]  

Top
Correspondence Address:
Narayanswami Sreeram
Heart Center, University Hospital of Cologne, Kerpenerstrasse 62, 50937 Cologne
Germany
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2069.93712

Rights and Permissions


    Figures

  [Figure 1], [Figure 2]

This article has been cited by
1 Bronchial compression following pulmonary artery stenting in single ventricle lesions: how to prevent, and how to decompress
J. Grohmann,B. Stiller,E. Neumann,A. Jakob,T. Fleck,G. Pache,M. Siepe,R. Höhn
Clinical Research in Cardiology. 2015;
[Pubmed] | [DOI]
2 Pulmonary artery stenosis in hybrid single-ventricle palliation: High incidence of left pulmonary artery intervention
Otto Rahkonen,Rajiv R. Chaturvedi,Lee Benson,Osami Honjo,Christopher A. Caldarone,Kyong-Jin Lee
The Journal of Thoracic and Cardiovascular Surgery. 2014;
[Pubmed] | [DOI]
3 Stenting for pulmonary artery stenosis complicated by univentricular physiology: Subanalysis of JPIC stent survey
Takanari Fujii,Hideshi Tomita,Shinichi Otsuki,Toshiki Kobayashi,Yasuo Ono,Satoshi Yazaki,Sung-Hae Kim,Toshio Nakanishi
Journal of Cardiology. 2014;
[Pubmed] | [DOI]



 

Top